117 related articles for article (PubMed ID: 22351098)
1. A new rat model of bone cancer pain.
Zhang R; Lao L
Methods Mol Biol; 2012; 851():261-73. PubMed ID: 22351098
[TBL] [Abstract][Full Text] [Related]
2. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia.
Zhang RX; Liu B; Wang L; Ren K; Qiao JT; Berman BM; Lao L
Pain; 2005 Nov; 118(1-2):125-36. PubMed ID: 16154703
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model.
Yin Q; Cheng W; Cheng MY; Fan SZ; Shen W
Behav Pharmacol; 2010 Oct; 21(7):595-601. PubMed ID: 20736819
[TBL] [Abstract][Full Text] [Related]
4. Intravenous injection of leconotide, an omega conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain.
Kolosov A; Aurini L; Williams ED; Cooke I; Goodchild CS
Pain Med; 2011 Jun; 12(6):923-41. PubMed ID: 21539704
[TBL] [Abstract][Full Text] [Related]
5. Electroacupuncture attenuates bone cancer pain and inhibits spinal interleukin-1 beta expression in a rat model.
Zhang RX; Li A; Liu B; Wang L; Ren K; Qiao JT; Berman BM; Lao L
Anesth Analg; 2007 Nov; 105(5):1482-8, table of contents. PubMed ID: 17959986
[TBL] [Abstract][Full Text] [Related]
6. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells.
Mao-Ying QL; Zhao J; Dong ZQ; Wang J; Yu J; Yan MF; Zhang YQ; Wu GC; Wang YQ
Biochem Biophys Res Commun; 2006 Jul; 345(4):1292-8. PubMed ID: 16725112
[TBL] [Abstract][Full Text] [Related]
7. Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain.
Cao F; Gao F; Xu AJ; Chen ZJ; Chen SS; Yang H; Yu HH; Mei W; Liu XJ; Xiao XP; Yang SB; Tian XB; Wang XR; Tian YK
Brain Res; 2010 Apr; 1326():162-73. PubMed ID: 20176002
[TBL] [Abstract][Full Text] [Related]
8. Antiallodynic effects of propentofylline Elicited by interrupting spinal glial function in a rat model of bone cancer pain.
Yao M; Chang XY; Chu YX; Yang JP; Wang LN; Cao HQ; Liu MJ; Xu QN
J Neurosci Res; 2011 Nov; 89(11):1877-86. PubMed ID: 21812015
[TBL] [Abstract][Full Text] [Related]
9. Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain.
Tong W; Wang W; Huang J; Ren N; Wu SX; Li YQ
Biochem Biophys Res Commun; 2010 May; 395(4):572-6. PubMed ID: 20399746
[TBL] [Abstract][Full Text] [Related]
10. Bone cancer pain and the role of RANKL/OPG.
Clohisy DR; Mantyh PW
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):293-300. PubMed ID: 15615497
[TBL] [Abstract][Full Text] [Related]
11. The intrathecally administered kappa-2 opioid agonist GR89696 and interleukin-10 attenuate bone cancer-induced pain through synergistic interaction.
Kim WM; Jeong CW; Lee SH; Kim YO; Cui JH; Yoon MH
Anesth Analg; 2011 Oct; 113(4):934-40. PubMed ID: 21788320
[TBL] [Abstract][Full Text] [Related]
12. [Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo].
Yao M; Yang JP; Wang LN; Cheng H; Zhang YB; Xu QN; Wu YW
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):880-4. PubMed ID: 18756951
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
Halvorson KG; Sevcik MA; Ghilardi JR; Rosol TJ; Mantyh PW
Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
[TBL] [Abstract][Full Text] [Related]
14. Heat and mechanical hyperalgesia in mice model of cancer pain.
Asai H; Ozaki N; Shinoda M; Nagamine K; Tohnai I; Ueda M; Sugiura Y
Pain; 2005 Sep; 117(1-2):19-29. PubMed ID: 16043290
[TBL] [Abstract][Full Text] [Related]
15. Superficial dorsal horn neuronal responses and the emergence of behavioural hyperalgesia in a rat model of cancer-induced bone pain.
Donovan-Rodriguez T; Dickenson AH; Urch CE
Neurosci Lett; 2004 Apr; 360(1-2):29-32. PubMed ID: 15082171
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms that generate and maintain bone cancer pain.
Mantyh PW; Hunt SP
Novartis Found Symp; 2004; 260():221-38; discussion 238-40, 277-9. PubMed ID: 15283453
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin diminishes advanced bone cancer pain.
Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
[TBL] [Abstract][Full Text] [Related]
19. Bone cancer pain.
Clohisy DR; Mantyh PW
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S279-88. PubMed ID: 14600620
[TBL] [Abstract][Full Text] [Related]
20. A rat model of bone inflammation-induced pain by intra-tibial complete Freund's adjuvant injection.
Yang CJ; Wang XW; Li X; Wu GC; Wang YQ; Mao-Ying QL
Neurosci Lett; 2011 Mar; 490(3):175-9. PubMed ID: 21182894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
